The use of Artificial Intelligence (AI) in the medicinal product lifecycle

The reflection paper on the use of artificial intelligence in the lifecycle of medicines outlines the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of human and veterinary medicines.
HumanScientific guidelines

This paper reflects on principles relevant to the application of AI and machine learning (ML) at any step of a medicines’ lifecycle, from drug discovery to the post-authorisation setting.

Keywords: artificial intelligence, AI, machine learning, ML, regulatory, medicine, human medicinal product, veterinary medicinal product

Current version

Document history

Share this page